| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.42 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |